Court’s Reliance Ruling In Securities Class Action Was Proper, Investors Argue

PHILADELPHIA — A federal district court did not abuse its discretion in ruling that a pharmaceutical company and certain of its senior executives failed to rebut the presumption of reliance in...

Already a subscriber? Click here to view full article